Article Versions Notes

Castañé H, Jiménez-Franco A, Martínez-Navidad C, Placed-Gallego C, Cambra-Cortés V, Perta A-M, París M, Castillo Dd, Arenas M, Camps J, et al. Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis. Antioxidants. 2023; 12(12):2038. https://doi.org/10.3390/antiox12122038

Castañé, Helena, Andrea Jiménez-Franco, Cristian Martínez-Navidad, Cristina Placed-Gallego, Vicente Cambra-Cortés, Adelina-Miruna Perta, Marta París, Daniel del Castillo, Meritxell Arenas, Jordi Camps, and et al. 2023. "Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis" Antioxidants 12, no. 12: 2038. https://doi.org/10.3390/antiox12122038

Castañé, H., Jiménez-Franco, A., Martínez-Navidad, C., Placed-Gallego, C., Cambra-Cortés, V., Perta, A.-M., París, M., Castillo, D. d., Arenas, M., Camps, J., & Joven, J. (2023). Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis. Antioxidants, 12(12), 2038. https://doi.org/10.3390/antiox12122038